TalkMed Group Ltd. | Cash Flow

Fiscal year is January-December. All values SGD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
35,805.00
46,585.00
45,487.00
45,488.00
38,538.00
34,003
Depreciation, Depletion & Amortization
8.00
32.00
174.00
266.00
366.00
376
Other Funds
-
-
-
-
1,600.00
5,572
Funds from Operations
28,788.00
39,483.00
40,416.00
40,938.00
32,709.00
28,807
Changes in Working Capital
6,913.00
11,949.00
67.00
3,880.00
1,721.00
1,272
Net Operating Cash Flow
35,701.00
27,534.00
40,483.00
44,818.00
30,988.00
30,079
Capital Expenditures
61.00
4.00
672.00
254.00
529.00
Sale of Fixed Assets & Businesses
-
-
1,200.00
-
-
Purchase/Sale of Investments
-
-
11,524.00
-
-
Net Investing Cash Flow
61.00
4.00
10,996.00
254.00
529.00
Cash Dividends Paid - Total
27,500.00
21,488.00
30,820.00
30,130.00
25,004.00
Net Financing Cash Flow
27,499.00
1,528.00
30,820.00
30,130.00
23,404.00
Net Change in Cash
8,141.00
26,002.00
1,333.00
14,434.00
7,055.00
Free Cash Flow
35,640.00
27,530.00
39,811.00
44,564.00
30,459.00
Change in Capital Stock
1.00
19,960.00
-
-
-

About TalkMed Group

View Profile
Address
101 Thomson Road
Singapore CE 307591
Singapore
Employees -
Website http://www.talkmed.com.sg
Updated 07/08/2019
Talkmed Group Ltd. operates as an investment holding company, which provides medical oncology services and stem cell transplant services. It operates through the Oncology Services and Stem Cell Services segments. The Oncology Services segment covers deals with oncology services to Parkway Cancer Centre.